Genetic Immunisation Protects Chimpanzees Against Malaria
Author Information
Author(s): Daubersies Pierre, Ollomo Benjamin, Sauzet Jean-Pierre, Brahimi Karima, Perlaza Blanca-Liliana, Eling Wijnand, Moukana Hubert, Rouquet Pierre, de Taisne Charles, Druilhe Pierre
Primary Institution: Institut Pasteur, Paris, France
Hypothesis
Can genetic immunization using Liver Stage Antigen-3 (LSA-3) provide protection against malaria in chimpanzees despite low immune responses?
Conclusion
Genetic immunization with LSA-3 can confer strong and reproducible protection against malaria in chimpanzees, even with low immune responses.
Supporting Evidence
- Three out of four immunized chimpanzees showed no parasitized red blood cells after sporozoite challenge.
- The protective effect was consistent across two separate challenges.
- Despite low antibody responses, the immune responses were sufficient to confer protection.
Takeaway
Scientists found that a special vaccine can help protect chimpanzees from malaria, even if their bodies don't make a lot of antibodies.
Methodology
Six adult chimpanzees were immunized with a DNA vaccine and then challenged with malaria sporozoites to assess protection.
Limitations
The small sample size of chimpanzees limits the statistical power of the findings.
Participant Demographics
Six adult chimpanzees with no previous exposure to malaria.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website